Kevin Malobisky

Advisor at ReNetx Bio

Dr. Malobisky is currently the Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics, where he is responsible for developing and executing all global regulatory strategies, a robust quality management system, and overall strategic operations across the organization. With over 30 years of executive leadership and global drug development experience, Dr. Malobisky has an established track record of success building and leading teams in both large pharmaceutical and small biotechnology organizations.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ReNetx Bio

1 followers

Changing lives through the REstoration of neural NETworks. ReNetx Bio's mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.


Industries

Employees

1-10

Links